Cease Trade Order

Dr. John Burba
Logan Anderson
(each referred to separately as the Insider)

And

International Battery Metals Ltd.

Section 164 of the Securities Act, R.S.B.C. 1996, c. 418
1 International Battery Metals Ltd. is a reporting issuer and has not filed:

1. annual audited financial statements for the year ended January 31, 2022, as
required under Part 4 of National Instrument 51-102 Continuous Disclosure
Obligations (NI 51-102), and
2. a Form 51-102F1 Management's Discussion and Analysis for the period ended
January 31, 2022, as required under Part 5 of NI 51-102
(the required records).

2 The Insider may have knowledge of, or access to, a material fact or material
change regarding International Battery Metals that has not been generally
disclosed.

3 International Battery Metals has agreed to file, immediately after this order is
granted, the Notice of Default and, if applicable, Default Status Reports, set out in
National Policy 12-203 Management Cease Trade Orders.

4 Under section 164(1) of the Act, the Executive Director orders that all trading by
the Insider in the securities of International Battery Metals cease until:

1. International Battery Metals files the required records, completed in
accordance with the Act and rules, and
2. the Executive Director revokes this order.

5 June 1, 2022

Anita Cyr, CPA, CA
Manager, Financial Reporting
Corporate Finance

News Release

Dr. John Burba reports

DELAY IN FILING AUDITED ANNUAL FINANCIAL STATEMENTS

The filing of International Battery Metals Ltd.'s audited annual financial statements for the year ended Jan. 31, 2022, including the related management discussion and analysis, and chief executive officer and chief financial officer certifications, were not filed by the required filing deadline of May 31, 2022.

The company has been preparing its financial statements to meet the filing deadline but was notified on Friday, May 27, 2022, by its auditor that certain requests pertaining to the disclosure of information concerning the company would need to be satisfied prior to the completion of the audit.

The company's staff is working diligently with its auditors and the company anticipates that it will be in a position to file the annual financial filings by no later than June 3, 2022.

The company has voluntarily applied to the applicable securities regulatory authorities and received a management cease trade order related to the company's securities to be imposed against all of the persons who are currently directors or officers of the company to trade securities of the company. The management cease trade order will be in effect until the annual financial Filings are filed. All other securityholders will still be able to trade in the securities of the company in accordance with applicable securities laws.

Until the annual financial filings are filed, the company intends to provide information in accordance with National Policy 12-203 Cease Trade Orders for Continuous Disclosure Defaults.

ASANTE ANNOUNCES PURCHASE OF
CHIRANO GOLD MINE IN GHANA

Vancouver, British Columbia, April 25, 2022 – Asante Gold Corporation (CSE:ASE |
FRANKFURT:1A9 | U.S.OTC:ASGOF) (“Asante” or the “Company”) is pleased to announce that it has
entered into a share purchase agreement with Kinross Gold Corporation (“Kinross”) to acquire Kinross’
90% interest in the Chirano Gold Mine (“Chirano”) for a total consideration of US$225 million (the
“Chirano Acquisition”). The Ghanaian government retains a 10% carried interest in Chirano.
The upfront consideration for the Chirano Acquisition will be comprised of US$115 million in cash and
US$50 million in common shares of Asante (“Asante Shares”) based on the 30-day volume-weighted
average price of the Asante Shares prior to closing of the Chirano Acquisition (“Closing”) and provided the
issuance of the Asante S hares will not result in Kinross exceeding a 9.9% share ownership in Asante.
Kinross will also receive a total deferred payment of US$60 million in cash, with 50% payable on the first
anniversary of Closing and the balance payable on the second anniversary of Closing. If the 9.9% share
ownership limit is reached, the remainder of the US$50 million in share consideration will be paid by
increasing the deferred cash payments in equal portions. Kinross has agreed that it will hold its Asante
Shares for at least 12 months following the Closing.

The transaction is expected to be completed on or around May 31, 2022. The Government of Ghana has
issued a Letter of No Objection to the change of control of Chirano and the transaction is not subject to a
financing condition.

Dave Anthony, President and CEO of Asante, stated: “We are excited to add the Chirano operation to our
base of gold production in Ghana. It presents an excellent opportunity for synergy with our other Ghanaian
assets and represents “the next step” for our vision to build a leading gold mining company in Ghana and
West Africa. Asante has deep ties to Ghana and is committed to sharing the benefits of its activities with
the local community and Ghana. Chirano is a well-run operation and our intention is to retain its employees,
to ensure a smooth transition of ownership, with uninterrupted production.”

Douglas MacQuarrie, Non-Executive Chairman of Asante, stated: “The Bibiani and Chirano assets will be
combined under one ownership, to cover an entire district scale gold trend exceeding 53km in length and
with past gold production of more than 8 million ounces. With two modern process plants located 20km
apart, exploration success anywhere along the gold trend can be efficiently accessed. Our recent exploration success at Bibiani-South Russel is indicative of the discovery potential that remains along the trend.”

Canaccord Genuity Corp. and Durose Asset Management Inc. are acting as financial advisors to Asante,
with Bennett Jones LLP acting as legal advisor, for the transaction.

About the Chirano Gold Mine
Chirano is an operating open-pit and underground mining operation located in southwestern Ghana,
immediately south of the Company’s Bibiani Gold Mine. Chirano was first explored and developed in
1996 and began production in October 2005. The mine comprises the Akwaaba, Suraw, Akoti South, Akoti
North, Akoti Extended, Paboase, Tano, Obra South, Obra, Sariehu and Mamnao open pits and the Akwaaba and Paboase underground mines. Gold Equivalent Production in 2021 was 154,668 oz on a 100% basis
(source Kinross Gold Corporation).

About Asante Gold Corporation
Asante is a gold exploration, development and operating company with a high-quality portfolio of projects
in Ghana, Africa’s largest and most reliable gold producer. Asante is currently focused on developing to
production its Bibiani and Kubi Gold mines located on the prolific Bibiani and Ashanti Gold Belts. Asante
has an experienced and skilled team of mine finders, builders and operators, with extensive experience in
Ghana.

Asante is listed on the Canadian Securities Exchange and the Frankfurt Stock Exchange and has announced plans to co-list its shares in Ghana. Asante is also exploring its Keyhole, Fahiakoba and Betenase projects for new discoveries, all adjoining or along strike of major gold mines near the centre of Ghana’s Golden Triangle.

Additional information is available on the Company’s website at www.asantegold.com.

About the Bibiani Gold Mine
Bibiani is a historically significant gold mine situated in the western region of Ghana, with previous gold
production close to 5 Moz. It is fully permitted with available mining and processing infrastructure on-site
consisting of a 3 million tonne per annum mill and processing plant, and existing surface and mining
infrastructure. Mining commenced in late February and first gold production is on track for Q3 2022.
The Current Mineral Resource Estimate for Bibiani, as reported in the Technical Report on the Bibiani
Gold Mine, Ghana, by Principal Author Ian M Glacken FAusIMM (CP), FAIG, CEng and Qualified Person
Dan Bansah MSc, MAusIMM (CP), FWAIMM, MGIG, dated November 7, 2021, and filed on SEDAR, is
Measured and Indicated 20.1 million tonnes at 2.71 grams of gold per tonne for 1.81 Moz of gold, plus
Inferred 8.41 million tonnes at 2.78 grams of gold per tonne for 0.75 Moz of gold from an open pit mine.
The Mineral Resource has been reported above a 0.65 g/t gold cut-off and has been depleted for both
historical open pit and underground development as of August 31, 2017. The Bibiani Main Pit mineral
resource has been prepared by Competent Persons (Optiro, 2017) using accepted industry practices and
have been classified and reported in accordance with the JORC Code (JORC, 2012). There are no material
differences between the definitions of Measured, Indicated and Inferred Mineral Resources under the CIM
Definition Standards and the equivalent definitions in the JORC Code. The Satellite pit resource is an
update completed in 2018 by Resolute Mining Limited. The Satellite pit resource is also reported above a
cut-off grade of 0.65 g/t gold inside a pit shell defined at a gold price of US$1,950. Mineral resources that
are not mineral reserves do not have demonstrated economic viability.

For further information please contact:

Dave Anthony, President & CEO: +1 647 382 4215 (Canada) or +233 55 879 3309 (Ghana) or
dave@asantegold.com
Malik Easah, Executive Director, malik@asantegold.com
Alec Rowlands, Capital Markets Consultant, alec@asantegold.com
Valentina Gvozdeva, Manager IR, valentina@asantegold.com
Kirsti Mattson, Media Relations, kirsti.mattson@gmail.com

High jacked? My guess is someone didn't get paid...

From IBAT's FB Page... Are Synthetic Fuels the Future?

https://www.bosch.com/stories/synthetic-fuels/?fbclid=IwAR3l6cAWOuNYd89r1e2tbdI6_QWZ6GvIMxdwinJ5ulF0GLZ58uVqveP1yQc

Is 600,000 Tonnes per year a lot??

https://www.autoweek.com/news/green-cars/amp37029490/gm-will-suck-lithium-from-the-salton-sea-to-make-batteries/?fbclid=IwAR2NtyCuBbOWn87cN_3bhP4wdiQKOPuBtFquwGsIFakD111CxGztEJ9Vg6o

ASANTE GOLD INTERSECTS 32.5 METERS WITH VISIBLE GOLD AT KUBI


ANNOUNCES C$5MILLION PRIVATE PLACEMENT –DRILLING UP DATE

Vancouver, British Columbia –March16, 2021–Asante Gold Corporation (CSE:ASE/ FRANKFURT:1A9/U.S.OTC:ASGOF)(“Asante” or the "Company")announces a private placement to accredited and exempt investors (the “Private Placement”) of up to 33,333,333units at CAD$0.15per unit (each a “Unit”), for gross proceeds of up to CAD$5.0 million. Each Unit will consist of one common share of the Company (a “Common Share”), and one Common Share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one additional Common Share at an exercise price of CAD$0.25at any time during the 24 months following the closing date. The Company is relying on exemptions from the prospectus requirements and applicable securities laws to issue the shares. All securities purchased under this offering will be subject to a four month and one day hold period. Directors and officers of the Company may participate in the private placement.

Proceeds from the placement will be used for working capital, and to further the exploration and development of the Company’s Kubi, Fahiakoba, Betenase and Keyhole gold projects in Ghana.

In addition, the first of three geotechnical holes on the Kubi Main Zone has been completed. DDHK21-001was collared on section 5970 north, approximately 100m to the north of the Kubi Pit.On this particular section, near the middle of the 1Kubi Main Mineral Resource, gold mineralization has previously been outlined by drilling to a depth of 450m. Recent 3D magnetic inversion modelling suggests that the structure that hosts the Kubi deposit extends to +3km in depth. At Kubi the gold is free milling and occurs within a near vertical1km long by 1m to 15m thick shear bounded ‘garnet’ zone. Gold is associated with up to 30% garnet and 15% sulfide mineralization and also occurs as coarse gold in late quartz veins.The drilling has intersected and confirmed garnet zone type mineralization over a core length of 32.5m (true width estimated at7.5m). Visible gold was noted.Geophysical logging of the core and the hole are underway to determine the geophysical ‘fingerprint’ of the gold mineralization for future property scale 3D geophysical modeling, as well as detailed sampling in order to obtain the‘bulk assay’ of the gold content, and to obtain samples for compressive strength testing.Two other holes are planned on this section in order to fully test the characteristics of the mineralization from surface to 100m in depth.

"Douglas R. MacQuarrie"President and CEO

Scientific and technical information contained in this news release has been reviewed and approved by Douglas R. MacQuarrie, P.Geo. (B.C.) Geology & Geophysics, the President and CEO of the Company, who is a "qualified person" under NI 43-101.1The Kubi Main Zone has a current NI 43-101mineralresource estimate, completed by SEMS Exploration Services Ltd. of Accra, Ghana: Measured Resources 0.66 million tonnes @ 5.30g/t for 112,000 ounces; Indicated Resources 0.66 million tonnes @ 5.65g/t for 121,000 ounces; and Inferred Resources 0.67 million tonnes @ 5.31g/t for 115,000 ounces, which is filed on SEDAR. Mineral resources that are not mineral reserves do not have demonstrated economic viability.

About Asante Gold Corporation

Asante has announced plans to co-list its shares on the Ghana Stock Exchange, and is continuing to develop its Kubi Gold Mine project to production. Asante is also exploring its’ Keyhole, Fahiakoba and Betenase concessions/options for new discoveries, all adjoining or along strike of major gold mines near the centre of Ghana’s Golden Triangle.Additional information is available on our web site at:www.asantegold.com

For further information please contact:Douglas MacQuarrie, President and CEO, tel: +1 604-558-1134; E-mail: douglas@asantegold.com

Valentina Gvozdeva, Business Development, E-mail: valentina@asantegold.com

Doreen Kent, Shareholder Communications, tel: +1 604-948-9450; E-mail: d.kent@eastlink.ca

Kirsti Mattson, Media Relations, E-mail: kirsti.mattson@gmail.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

LEI Number: 529900F9PV1G9S5YD446.

H-Source Holdings and Relevium Technologies Partner

for the Strategic Development and Global Supply of Personal Protective Equipment


Jul 13, 2020, 20:15 ET


VANCOUVER, July 13, 2020 /CNW/ - H-Source Holdings Ltd. (TSXV: HSI) (OTCQB: HSCHF) (the "Company" or "H-Source") is pleased to announce it has entered into a Letter of Intent ("LOI") with Relevium Technologies ("Relevium"), a corporation strategically focused on the acquisition and distribution of products and technologies with health and wellness in mind, to partner in the development, strategic sourcing and supply of global Personal Protective Equipment ("PPE") requirements due to COVID-19.

The HSource1 proprietary platform is focused on supplying the significant demand for PPE products by providing a central location for hospitals, governments, and businesses to procure highly needed medical surgical supplies, pharmaceuticals, capital equipment and wellness products. Relevium has established contracts with multiple vendors and products that are approved for global distribution, greatly increasing opportunities for supporting a healthier world.

H-Source and Relevium have been in discussion for several months about partnering to make the CleanCare line available through HSource1, as well as other PPE products. HSource1 is a fully secured and auditable platform that connects buyers and suppliers in a secured, compliant, and transparent manner. The platform is registered and approved in 35 states in the USA, as well as Canada and Europe. H-Source partners with EY (formerly Ernst & Young) to deploy the platform.

Strategic Partnership

H-Source and Relevium will be cooperating to list the Company's product offerings and incorporating its newly developed network of PPE products, vendors and buyers onto the H-Source1 platform. Relevium's new business, Bioganix CleanCare is now poised to expand to global markets utilizing the efficiencies of HSource1.

Both companies have expressed their intention, in the LOI, to exchange equity and share resources to solidify the partnership.

Aurelio Useche, CEO of Relevium Technologies stated: "We are extremely pleased to partner with John and his team to develop and master the global supply chain of personal protection products not only during this pandemic, but also to service the New Economic standard of supplying services to consumers. We look forward to a mutually rewarding and profitable cooperation"

John Kupice, CEO of H-Source stated "We are excited to partner with Aurelio and Relevium, adding Bioganix and their other innovative products to the HSource1 Global Virtual Purchasing Organization Platform. Jointly we will service current PPE needs as well as enable new efficient post COVID-19 supply chain processes and distribution models."

About H-Source Holdings Ltd.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a proprietary technology solution that provides a private, secure and Software As A Service ("SAAS") platform for members to buy, sell, track, and transfer medical supplies, pharmaceuticals, capital equipment and products. Integrated Artificial Intelligence ("AI") and Business Intelligence ("BI") enhance the data analytics for supply chain optimization. The platform is FDA and DSCSA compliant for pharmaceuticals including serialization, ownership and custody in extended modules. Complete Blockchain integration is offered, as an add-on, for additional security and traceability. The platform is designed to increase supply chain efficiency and reduce costs, moving products directly from OEMs on a B2B and / or B2C model. For more information, please visit http://h-source.com/.

About Relevium Technologies

Relevium is a publicly traded Company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly owned subsidiaries:

BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe.

Relevium's premium brands are sold at some of the world's largest retailers including Walmart.com and Amazon.com.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice
CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company's shares on the TSXV and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

SOURCE H-Source Holdings Ltd.

"The Trump administration is in a race to outpace the coronavirus as it seeks to replenish the country's national supply stockpile, despite conflicting messaging from officials about the potential severity of a second wave of the virus."


https://www.cnn.com/2020/06/23/politics/coronavirus-supply-strategic-national-stockpile/index.html?utm_source=fbCNN&utm_medium=social&utm_content=2020-06-23T19%3A29%3A10&utm_term=link

"The Trump administration is in a race to outpace the coronavirus as it seeks to replenish the country's national supply stockpile, despite conflicting messaging from officials about the potential severity of a second wave of the virus."



https://www.cnn.com/2020/06/23/politics/coronavirus-supply-strategic-national-stockpile/index.html?utm_source=fbCNN&utm_medium=social&utm_content=2020-06-23T19%3A29%3A10&utm_term=link

Healthcare transactions Totaling $12,000,000

"We are excited to partner with CGL Global and ODOO to provide needed medical supplies including (PPE) direct from manufacturers to help in the fight of COVID-19 in Germany and countries across Europe. We have completed healthcare transactions globally totaling $12,000,000, and look forward to growing this with products across Europe, specifically with this current focus on much needed PPE equipment to help medical professionals and labor forces stay diligent and safe during this uncertain period" stated John Kupice CEO/Director H-Source Holdings, Ltd.

Healthcare Transactions Totaling $12,000,000

"We are excited to partner with CGL Global and ODOO to provide needed medical supplies including (PPE) direct from manufacturers to help in the fight of COVID-19 in Germany and countries across Europe. We have completed healthcare transactions globally totaling $12,000,000, and look forward to growing this with products across Europe, specifically with this current focus on much needed PPE equipment to help medical professionals and labor forces stay diligent and safe during this uncertain period" stated John Kupice CEO/Director H-Source Holdings, Ltd.

H-Source announces HSource1 In Europe for Medical Supplies and COVID-19

News provided by
H-Source Holdings Ltd.

May 12, 2020, 20:38 ET

Share this article

VANCOUVER, May 12, 2020 /CNW/ - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce the release of HSource1, its state of the art healthcare supplies platform, now online in the European Union (www.hsource1.eu), as part of an overall strategy to improve supply chain efficiency. The platform is focused on providing a central location for hospitals, governments, and businesses to procure highly needed medical supplies including medical surgical supplies, pharmaceuticals, capital equipment, and Personal Protective Equipment ("PPE") products for Germany and across Europe. The Company has partnered with CGL Global ("CGL"), who is procuring verified sourcing of products as well as providing fully integrated delivery channels across Europe. HSource1 is a private network, and all members and products are vetted by H-Source, increasing the accuracy and confidence of all participants, including buyers and sellers. Additionally, H-Source is working jointly with ODOO on the Hsource1 platform. The combined efforts of H-Source's healthcare focus and CGL Globals' various supply chain relationships, integrated with ODOO's technical resources, have created a unique platform to support a variety of solutions for front-line emergency workers and healthcare professionals during this COVID-19 pandemic.

"We are proud to help and partner with associations and businesses that fight the COVID-19 crisis. Our new partner H-Source will have a positive impact by helping hospitals and government healthcare facilities stay safe during this crisis" commented Fabien Pinckaers, Founder and CEO of ODOO.

"We are excited to partner with CGL Global and ODOO to provide needed medical supplies including (PPE) direct from manufacturers to help in the fight of COVID-19 in Germany and countries across Europe. We have completed healthcare transactions globally totaling $12,000,000, and look forward to growing this with products across Europe, specifically with this current focus on much needed PPE equipment to help medical professionals and labor forces stay diligent and safe during this uncertain period" stated John Kupice CEO/Director H-Source Holdings, Ltd.

About CGL Global
CGL Global is a vertically integrated international company focused in the Healthcare Sector. CGL Global partners with various Research & Development facilities, Universities, Healthcare Professionals, Government Agencies and cutting-edge technology focused Companies to engage in the development and commercialization of various therapeutic formulations for the Pharmaceutical & Medicinal sectors, as well as developing Health and Wellness products using innovative, patent-protected drug delivery technologies. Our Vision and Mission is focused on allowing people to live their very best lives.

About ODOO
Odoo is a leading provider of all-in-one, open-source business software for businesses worldwide. Founded in 2005, Odoo thrives in a unique and fully open ecosystem combining the resources of its community and partners to deliver a full range of easy-to-use, integrated and scalable business applications. Odoo has offices in the U.S., Belgium, Luxembourg, India, Hong Kong, and Dubai. For more information, please visit: www.odoo.com.

About H-Source Holdings Ltd.
H-Source Holdings Ltd. is a proprietary, patented technology company operating within the healthcare industry through its wholly-owned subsidiary, H-Source, Inc. The Company has developed an advanced technology solutions stack that provides participating members a private, secure, Software As A Service ("SAAS") platform to engage in the buy, sell, track, and transfer of medical supplies, pharmaceuticals, capital equipment, and medical devices. Integrating advanced Artificial Intelligence ("AI") and Business Intelligence ("BI") enhance the data analytics for supply chain optimization. The platform is FDA and DSCSA compliant for pharmaceuticals and GS-1 UDI/GTIN for devices including serialization, ownership, and custody in extended modules. Blockchain is offered as an add-on, at an additional cost, for robust security and traceability. Additionally, the H-Source platform provides all the accounting and data allowing buyers and sellers to capture product transactions and custody movements. This platform is designed to increase and maximize supply chain efficiency while reducing costs by moving products directly from manufacturers, providers, and distributors to businesses or consumers. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice
CEO & Director

H-Source announces HSource1 In Europe for Medical Supplies and COVID-19

News provided by
H-Source Holdings Ltd.

May 12, 2020, 20:38 ET

Share this article

VANCOUVER, May 12, 2020 /CNW/ - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce the release of HSource1, its state of the art healthcare supplies platform, now online in the European Union (www.hsource1.eu), as part of an overall strategy to improve supply chain efficiency. The platform is focused on providing a central location for hospitals, governments, and businesses to procure highly needed medical supplies including medical surgical supplies, pharmaceuticals, capital equipment, and Personal Protective Equipment ("PPE") products for Germany and across Europe. The Company has partnered with CGL Global ("CGL"), who is procuring verified sourcing of products as well as providing fully integrated delivery channels across Europe. HSource1 is a private network, and all members and products are vetted by H-Source, increasing the accuracy and confidence of all participants, including buyers and sellers. Additionally, H-Source is working jointly with ODOO on the Hsource1 platform. The combined efforts of H-Source's healthcare focus and CGL Globals' various supply chain relationships, integrated with ODOO's technical resources, have created a unique platform to support a variety of solutions for front-line emergency workers and healthcare professionals during this COVID-19 pandemic.

"We are proud to help and partner with associations and businesses that fight the COVID-19 crisis. Our new partner H-Source will have a positive impact by helping hospitals and government healthcare facilities stay safe during this crisis" commented Fabien Pinckaers, Founder and CEO of ODOO.

"We are excited to partner with CGL Global and ODOO to provide needed medical supplies including (PPE) direct from manufacturers to help in the fight of COVID-19 in Germany and countries across Europe. We have completed healthcare transactions globally totaling $12,000,000, and look forward to growing this with products across Europe, specifically with this current focus on much needed PPE equipment to help medical professionals and labor forces stay diligent and safe during this uncertain period" stated John Kupice CEO/Director H-Source Holdings, Ltd.

About CGL Global
CGL Global is a vertically integrated international company focused in the Healthcare Sector. CGL Global partners with various Research & Development facilities, Universities, Healthcare Professionals, Government Agencies and cutting-edge technology focused Companies to engage in the development and commercialization of various therapeutic formulations for the Pharmaceutical & Medicinal sectors, as well as developing Health and Wellness products using innovative, patent-protected drug delivery technologies. Our Vision and Mission is focused on allowing people to live their very best lives.

About ODOO
Odoo is a leading provider of all-in-one, open-source business software for businesses worldwide. Founded in 2005, Odoo thrives in a unique and fully open ecosystem combining the resources of its community and partners to deliver a full range of easy-to-use, integrated and scalable business applications. Odoo has offices in the U.S., Belgium, Luxembourg, India, Hong Kong, and Dubai. For more information, please visit: www.odoo.com.

About H-Source Holdings Ltd.
H-Source Holdings Ltd. is a proprietary, patented technology company operating within the healthcare industry through its wholly-owned subsidiary, H-Source, Inc. The Company has developed an advanced technology solutions stack that provides participating members a private, secure, Software As A Service ("SAAS") platform to engage in the buy, sell, track, and transfer of medical supplies, pharmaceuticals, capital equipment, and medical devices. Integrating advanced Artificial Intelligence ("AI") and Business Intelligence ("BI") enhance the data analytics for supply chain optimization. The platform is FDA and DSCSA compliant for pharmaceuticals and GS-1 UDI/GTIN for devices including serialization, ownership, and custody in extended modules. Blockchain is offered as an add-on, at an additional cost, for robust security and traceability. Additionally, the H-Source platform provides all the accounting and data allowing buyers and sellers to capture product transactions and custody movements. This platform is designed to increase and maximize supply chain efficiency while reducing costs by moving products directly from manufacturers, providers, and distributors to businesses or consumers. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice
CEO & Director

H-Source Holdings launches new website and opens East Coast office...

https://www.h-source.com/

H-Source Holdings launches new website and opens East Coast office...

https://www.h-source.com/

H-Source MD&A

The most important announcement early in Q4 is our partnering with EY (one of the “Big 4” global service providers) to deploy the H-Source software platform on the EY OpsChain Blockchain platform. We are jointly marketing opportunities related to supply chain transformation for medical supplies, equipment, and pharmaceuticals. This is core to our strategic plan to pivot to more software engagements. The joint projects will include license fees, transaction fees, and success or shared risk fees. We expect revenue from this initiative starting late Q1 of 2020. We are bringing a global nutraceutical distributor live on the H-Source platform in Europe and Canada late in Q4 of 2019. This is a project that showcases our global functionality including:

1.Ability to host and transact in the European Union with localization for language and currency

2.Track and trace capability for FDA and Swiss medical products

3.Provide a Canadian distribution network for products in local currency

4.Positive impact in 2020 as we help the distributor expand its global operations. We have added 20 independent sales representatives as of mid-November of 2019. We hope to see impacts from these representatives in Q1 of 2020.

Currently, H-Source pursues its growth strategy by:

•Continue with the Pilot of the H-Source/EY platform on OpsChain

•Add experienced software professionals to assist with software engagement acquisition and delivery experience on a variable compensation model (“eat what you kill”) based on profitability

•Expand existing software engagement pipeline for the joint H-Source/EY product offering

•Deploying independent sales representatives in select markets to enhance sales and convert contracted facilities to active facilities on the H-Source platformoFocusing on listing products that turn faster at predictable prices and marginsoOffering additional enhanced services to our clients where H-Source provides additional touch –labor for higher transaction fees with the addition of independent sales representatives

•Continue to expand Nutraceutical clients

•Maintaining Joint Marketing relationships with multiple state hospital associations and metropolitan hospital councils and associations

•Licensing our platform to medical facilities plus transaction fees

•Distributing products from third parties or Original Equipment Manufacturers (“OEM”) thru the platform

H-Source MD&A

The most important announcement early in Q4 is our partnering with EY (one of the “Big 4” global service providers) to deploy the H-Source software platform on the EY OpsChain Blockchain platform. We are jointly marketing opportunities related to supply chain transformation for medical supplies, equipment, and pharmaceuticals. This is core to our strategic plan to pivot to more software engagements. The joint projects will include license fees, transaction fees, and success or shared risk fees. We expect revenue from this initiative starting late Q1 of 2020. We are bringing a global nutraceutical distributor live on the H-Source platform in Europe and Canada late in Q4 of 2019. This is a project that showcases our global functionality including:

1.Ability to host and transact in the European Union with localization for language and currency

2.Track and trace capability for FDA and Swiss medical products

3.Provide a Canadian distribution network for products in local currency

4.Positive impact in 2020 as we help the distributor expand its global operations. We have added 20 independent sales representatives as of mid-November of 2019. We hope to see impacts from these representatives in Q1 of 2020.

Currently, H-Source pursues its growth strategy by:

•Continue with the Pilot of the H-Source/EY platform on OpsChain

•Add experienced software professionals to assist with software engagement acquisition and delivery experience on a variable compensation model (“eat what you kill”) based on profitability

•Expand existing software engagement pipeline for the joint H-Source/EY product offering

•Deploying independent sales representatives in select markets to enhance sales and convert contracted facilities to active facilities on the H-Source platformoFocusing on listing products that turn faster at predictable prices and marginsoOffering additional enhanced services to our clients where H-Source provides additional touch –labor for higher transaction fees with the addition of independent sales representatives

•Continue to expand Nutraceutical clients

•Maintaining Joint Marketing relationships with multiple state hospital associations and metropolitan hospital councils and associations

•Licensing our platform to medical facilities plus transaction fees

•Distributing products from third parties or Original Equipment Manufacturers (“OEM”) thru the platform

H-Source another Amazon

H-Source another Amazon...

"Aside from excess inventories, the Company has also addressed the possibility of including OEM and/or third party products on the platform. This one is interesting to us, but we think it also has some caveats that we won’t belabor but will at least address. First, establishing a virtual marketplace where a host of enterprises can market/sell their products to others is a proven model. Amazon is of course the glaring example although there are certainly others as well. That approach has been especially attractive to sellers (largely businesses and/or OEMs) that may lack the ability to afford and/or scale broad marketing and distribution campaigns. Clearly there are examples of products that experienced wild success that absent the Amazon platform would likely never have done so. While selling OEM healthcare products in a virtual marketplace certainly has some unique caveats that for instance, selling a winter coat on Amazon may not, there are some similarities worth noting. In the end, since the advent of the internet, many industries have seen their legacy distribution chains disintermediated, disrupted and even dismantled because of the efficiencies and the transparencies provided by open virtual markets. In an industry rife with inefficiency, it is almost hard to believe that healthcare supply chains have not been dragged kicking and screaming into the same paradigm. Again, we think there are good reasons why healthcare supply chains have not been substantially impacted by technology, but there are also good reasons why they should be and as with other industries, the good reasons often boil down to better transparency. Increased transparency is not always good for everyone in an industry. Like the mandating of electronic medical records technology, we suspect healthcare is going to find itself in the cross hairs of additional technological change, either as a matter of economic necessity, government edict or both. We can see advantages for (some) OEMs as well as for their customers to utilize exchanges/platforms like H-Sources and we can envision some resistance as well."

H-Source another Amazon

H-Source another Amazon...

"Aside from excess inventories, the Company has also addressed the possibility of including OEM and/or third party products on the platform. This one is interesting to us, but we think it also has some caveats that we won’t belabor but will at least address. First, establishing a virtual marketplace where a host of enterprises can market/sell their products to others is a proven model. Amazon is of course the glaring example although there are certainly others as well. That approach has been especially attractive to sellers (largely businesses and/or OEMs) that may lack the ability to afford and/or scale broad marketing and distribution campaigns. Clearly there are examples of products that experienced wild success that absent the Amazon platform would likely never have done so. While selling OEM healthcare products in a virtual marketplace certainly has some unique caveats that for instance, selling a winter coat on Amazon may not, there are some similarities worth noting. In the end, since the advent of the internet, many industries have seen their legacy distribution chains disintermediated, disrupted and even dismantled because of the efficiencies and the transparencies provided by open virtual markets. In an industry rife with inefficiency, it is almost hard to believe that healthcare supply chains have not been dragged kicking and screaming into the same paradigm. Again, we think there are good reasons why healthcare supply chains have not been substantially impacted by technology, but there are also good reasons why they should be and as with other industries, the good reasons often boil down to better transparency. Increased transparency is not always good for everyone in an industry. Like the mandating of electronic medical records technology, we suspect healthcare is going to find itself in the cross hairs of additional technological change, either as a matter of economic necessity, government edict or both. We can see advantages for (some) OEMs as well as for their customers to utilize exchanges/platforms like H-Sources and we can envision some resistance as well."

It looks like something is up...

Over 500 medical facilities are now contracted (~10% of the US Hospital Market) with 300 onboard the platform

· Medical facilities are now actively transacting with increasing volumes

H-Source Announces Increasing Transaction Volume and Corporate Update

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 6, 2017) - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce that during the quarter over 500 medical facilities are now contracted for the platform resulting in increased transaction volume.

"We set strong objectives for fiscal 2017 including, increasing our network by adding hospitals and medical facilities, monetizing the H-Source platform, strengthening our technology enhancements, and supporting greater supply chain cost recovery and savings. We have made progress in the first half of the year and will continue to execute our growth plan by adding a diverse array of medical facilities to the platform, strengthen inventory offerings and increase transaction volumes. Transactions that started in the second quarter will continue to grow moving forward. Additionally, we are now able to leverage and expand the H-Source Platform in new ways that will become more evident in upcoming quarters," said John Kupice, CEO and director of H-Source.

Key milestones and for the first half of fiscal 2017 include:

· We are experiencing repeated participation from member facilities and continue to add functionality and services that drive increased adoption.

· Our platform includes over 300 medical facilities, that are now onboarded, our number of mature and transacting facilities continues to grow as we add new customers and implement our account management program. Our expanded platform functionality and support resulted in higher customer interaction that resulted in increased network inventory and liquidity. Customer use is a key metric that has showed steady uptick quarter over quarter.

· We continue to add functionality and scalability to the H-Source Platform at a measured pace to ensure our offering is enhanced and the customer experience remains exceptional. Specifically, we expanded our ability beyond managing idle inventory for hospitals and are now targeting a broader portion of the medical supply chain for a variety of medical facilities. We are in discussions or implementation phase with multiple new customers, including large Hospital IDNs (Integrated Delivery Networks) and State hospital associations. This expanded offering provides potential licensing revenue and increased transactions.

· Our previously announced partnership with BidMed has been a success and provides a unique solution and value to our customers which includes sourcing capital equipment, capital asset valuation, tracking, and liquidation services. We are looking forward to the upcoming quarters as we continue to grow our joint service offerings.

About H-Source Holdings Ltd.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and trusted marketplace for member hospitals to buy, sell and transfer devices, pharmacuiticals, capital equipment and supplies with each other. Member hospitals can conduct secure transactions within Integrated Delivery Networks, complete H-Source network or customize their own group hospitals using H-Source's built-in filters. This marketplace network is specifically designed to reduce health care costs and medical product waste. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice, CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company's shares on the TSXV and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
CONTACT INFORMATION

· H-Source Holdings Ltd.
John Kupice
CEO & Director
1-888-900-4549
jkupice@h-source.com

Nicole Marchand
416-428-3533
investors@h-source.com





Nicole Marchand

Investor Relations

t. (416) 428-3533

e.nicole@nm-ir.com

Over 500 medical facilities are now contracted (~10% of the US Hospital Market) with 300 onboard the platform

· Medical facilities are now actively transacting with increasing volumes

H-Source Announces Increasing Transaction Volume and Corporate Update

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 6, 2017) - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce that during the quarter over 500 medical facilities are now contracted for the platform resulting in increased transaction volume.

"We set strong objectives for fiscal 2017 including, increasing our network by adding hospitals and medical facilities, monetizing the H-Source platform, strengthening our technology enhancements, and supporting greater supply chain cost recovery and savings. We have made progress in the first half of the year and will continue to execute our growth plan by adding a diverse array of medical facilities to the platform, strengthen inventory offerings and increase transaction volumes. Transactions that started in the second quarter will continue to grow moving forward. Additionally, we are now able to leverage and expand the H-Source Platform in new ways that will become more evident in upcoming quarters," said John Kupice, CEO and director of H-Source.

Key milestones and for the first half of fiscal 2017 include:

· We are experiencing repeated participation from member facilities and continue to add functionality and services that drive increased adoption.

· Our platform includes over 300 medical facilities, that are now onboarded, our number of mature and transacting facilities continues to grow as we add new customers and implement our account management program. Our expanded platform functionality and support resulted in higher customer interaction that resulted in increased network inventory and liquidity. Customer use is a key metric that has showed steady uptick quarter over quarter.

· We continue to add functionality and scalability to the H-Source Platform at a measured pace to ensure our offering is enhanced and the customer experience remains exceptional. Specifically, we expanded our ability beyond managing idle inventory for hospitals and are now targeting a broader portion of the medical supply chain for a variety of medical facilities. We are in discussions or implementation phase with multiple new customers, including large Hospital IDNs (Integrated Delivery Networks) and State hospital associations. This expanded offering provides potential licensing revenue and increased transactions.

· Our previously announced partnership with BidMed has been a success and provides a unique solution and value to our customers which includes sourcing capital equipment, capital asset valuation, tracking, and liquidation services. We are looking forward to the upcoming quarters as we continue to grow our joint service offerings.

About H-Source Holdings Ltd.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and trusted marketplace for member hospitals to buy, sell and transfer devices, pharmacuiticals, capital equipment and supplies with each other. Member hospitals can conduct secure transactions within Integrated Delivery Networks, complete H-Source network or customize their own group hospitals using H-Source's built-in filters. This marketplace network is specifically designed to reduce health care costs and medical product waste. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice, CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company's shares on the TSXV and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
CONTACT INFORMATION

· H-Source Holdings Ltd.
John Kupice
CEO & Director
1-888-900-4549
jkupice@h-source.com

Nicole Marchand
416-428-3533
investors@h-source.com





Nicole Marchand

Investor Relations

t. (416) 428-3533

e.nicole@nm-ir.com

MSX Pre-Market..

50,000 bid at 0.09 and 20,000 offered at 0.10.

"The ore body area is mine and MSX is in."

So where is the new agreement between you and MSX??? At this point all MSX is is a VERY over priced shell!!

Re: Mountainstar Gold extends warrants by one year

Why would you bother to extend warrants that are so far out of the money? Management must know the stock will be trading at a much higher price in the next year...

He said "can make"...

Barrick eyes way forward at Pascua-Lama; Company signs agreement with Chile to proceed with copper mine

08/22/2014 | 11:16am US/Eastern


A NEW memorandum of understanding between indigenous peoples in Chile and Barrick Gold could be the first step in a restarting the stalled Pascua-Lama Mine on the border of Chile and Argentina.

Reuters reported that Barrick has come to an initial understanding with 15 of 18 local communities. Work at the mine was halted last year because of permitting issues, cost overruns, falling gold prices, and strong and organized opposition of the local Diaguita indigenous communities. Barrick had invested $5 billion before halting work.

The new memorandum is seen as an initial step toward bringing the two sides together, Lorenzo Soto, the lawyer for the Diaguita, told Reuters.

"A new phase in the way that large-scale mining is done in Chile has begun," said Soto.

Barrick's office in Chile said in a statement that the new initiative leaves behind the "sourness" of the past.

"Although Pascua-Lama is suspended today, our aim is to obtain the permits to restart construction," Barrick said. The company recently met with the Chilean mining minister to express its interest in continuing with the project, the minister told Reuters.

Barrick's agreement with the indigenous peoples will last six months, during which time the company will provide project details to the communities to allow corroboration by experts, a process that will be funded by the Toronto-based miner, Soto said.

Should that process be successful, Barrick will enter a dialogue phase that could last two years or more, he said, adding that the company would not restart construction until it is complete.

That phase may include the payment of an "indigenous royalty." Although no legislation for such a mechanism exists "there is nothing to stop it being created," Soto said.

However, Chile's mining minister, Aurora Williams, said she did not believe that such a payment would be the way forward.

"In practice, that's paying to resolve the situation and we think that dialogue is what is needed," she told reporters.

(c) 2014 Society for Mining, Metallurgy, and Exploration, Inc.

Barrick mothballs Pascua-Lama

Frik Els | July 31, 2014

Barrick mothballs Pascua-Lama

Top gold miner Barrick Gold (NYSE:ABX TSE:ABX) yesterday reported financial results that showed a drop in production, further trimming of capex and costs, new directors and a quarterly loss.

Toronto-based Barrick also said its troubled Pascua Lama project in South America is now on care and maintenance after the company spent $300 million to complete the ramp-down of the project which straddles the Chilean-Argentinian border.

Barrick gold stopped construction of Pascua Lama in October as part of its cost and debt-reduction program. The company, worth $23 billion on the TSX, has already spent $5 billion on the project which could have a final bill in excess of $8.5 billion after a series of cost overruns.

But any decision to restart Pascua Lama seems far off, judging by the carefully worded statement accompanying the company's financials:

A decision to restart development will depend on improved economics and reduced uncertainty related to legal and regulatory requirements. To improve execution and cost control, remaining development will take place in distinct stages with specific work programs and budgets. Barrick continues to explore opportunities to improve the project's risk-adjusted returns, including strategic partnerships or royalty and other income streaming agreements.

During the second quarter, Barrick signed a Memorandum of Understanding (MoU) with a group of 15 Diaguita indigenous communities and associations in Chile's Huasco province. The MoU marks a first step in establishing dialogue and working to build trust with members of this important stakeholder group. As part of the MoU, Barrick will make technical and environmental information about the Pascua-Lama project available to the communities and provide financial resources and materials required to support analysis of this information.

The technically and politically challenging project high in the Andes launched in 2006 (at the time initial capex costs were pegged at $1.5 billion), suffered a number of defeats in Chilean courts about water use and the impact on glaciers in the area.

In contrast Argentina has been a vigorous backer of the project.

While only around a fifth of the deposit is located in Argentina many of the above-ground facilities will be built on that side of the border. Barrick earlier this year laid off 1,500 of the 5,000 workers on the Argentinian side.

If, and it's a big if, Pascua Lama goes into production the mine is expected to produce about 800,000 to 850,000 ounces of gold and 35 million ounces of silver in the first five years of its 25 year life.

Pascua Lama is also the subject of a class action lawsuit filed last month on behalf of investors who acquired Barrick stock between May 7, 2009 and May 23, 2013.

Shares in the $21.3 billion company lost 44% of its value over that time period, with a large chunk of the losses coming in April and May last year when the Toronto-based firm tapped markets for $3 billion to pay down debts.

The class actions allege that Barrick Gold shareholders lost billions of dollars as a result of Barrick’s "misrepresentations and failures" regarding the stalled project.

Yes I have one question? Where is your offer? The market is .105 to .75... We need your stock. Offer it!!!

Chile's Supreme Court begins hearings on Barrick Gold’s appeal to $16m fine

Cecilia Jamasmie | July 8, 2014

Construction at Pascua Lama, which straddles the Chile-Argentina border, has been indefinitely postponed due to legal issues in Chile and Barrick's own decision to halt works in October.

Chile's Supreme Court is due Tuesday to begin hearing an appeal filed by Canadian miner Barrick Gold (NYSE, TSX: ABX) against the environmental watchdog over a US$16 million fine it imposed last year for several permit breaches at the now shelved Pascua Lama gold-silver project.

The appeal follows a confusing ruling in March this year that revoked the penalty — the largest ever imposed in the country— over alleged mishandling of the process by the regulator

The appeal follows a confusing ruling in March this year that revoked the penalty — the largest ever imposed in the country— over alleged mishandling of the process by the regulator, the Superintendence for the Environment (SMA).

The resolution, however, not only ordered the Toronto-based to keep Pascua Lama’s operations halted, but instructed the SMA to re-write the resolution containing the fine, as it said it contained a number of "errors and illegalities."

The move brought new challenges and the possibility of even higher fines for Barrick, which insists the process leading to the multimillion fine was conducted according to law, El Pulso (in Spanish) reports.

Pascua Lama, which would produce about 800,000 to 850,000 ounces of gold a year in the first full five years of its 25 year life, was scheduled to start production in the second half of this year.

However, construction at the project site, which straddles the Chile-Argentina border, has been indefinitely postponed because of legal issues in Chile and the company's own decision to halt works in October, after investing $5 billion in it.

The mine was set to become one of the top gold and silver mines in Chile, the world's No.1 copper producer.



http://www.mining.com/chiles-supreme-court-begins-hearings-on-barrick-golds-appeal-to-16m-fine-90958/?utm_source=digest-en-au-140708&utm_medium=email&utm_campaign=digest

Pan American Goldfields Ltd.: Notice of Litigation

2014-05-06 11:41 ET - News Release

TORONTO, ONTARIO -- (Marketwired) -- 05/06/14

Pan American Goldfields Ltd. (the "Company") (OTCQX: MXOM), announces that a lawsuit (mercantile ordinary procedure) was filed by Corporativo Minero with the Second Civil District Court of the Morelos District, Chihuahua (the "Lawsuit"), and notified to the Company's Mexican subsidiary, Sunburst Mining De Mexico ("Sunburst") on March 21, 2014, suing Sunburst, Minera Rio Tinto, S.A. de C.V. ("Rio Tinto"), the Company's partner and operator in Mexico and Ejido Piedras Verdes y su anexo Cieneguilla Lluvia de Oro (the "Ejido") alleging, amongst other matters, a breach of contract following a supposed change of ownership at Corporativo Minero. The Company believes the suit is spurious and without merit. Accordingly, Sunburst has filed a response refuting the claim. Together with MRT, the Company is working to resolve the issue quickly and with a view to minimising costs insofar as is possible.

Emilio Alvarez, CEO

Pan American Gold Fields Ltd.

About Pan American Goldfields Ltd.

Pan American Goldfields is a precious metals mining and exploration company. Its focus is the production of gold and silver and the development and expansion of its La Cieneguita mine in Mexico's prolific Sierra Madre gold-silver belt.

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the United States private securities litigation reform act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Statements contained in this news release that are not historical facts are forward-looking information that involves known and unknown risks and uncertainties. Forward-looking statements in this news release include, but are not limited to, statements with respect to the potential Transaction, the completion of a private placement, the benefits of the potential Transaction, the merits of the mineral properties of Pan American, the future performance of Pan American, mineral resource estimates and the Company's plans and exploration programs for its mineral properties, including the timing of such plans and programs. In certain cases, forward-looking statements can be identified by the use of words such as "plans", "has proven", "expects" or "does not expect", "is expected", "potential", "appears", "budget", "scheduled", "estimates", "forecasts", "at least", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "should", "might" or "will be taken", "occur" or "be achieved".

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and other factors include, among others, uncertainties inherent in the estimation of mineral resources; commodity prices; changes in general economic conditions; market sentiment; currency exchange rates; the Company's ability to continue as a going concern; the Company's ability to raise funds through equity financings; risks inherent in mineral exploration; risks related to operations in foreign countries; future prices of metals; failure of equipment or processes to operate as anticipated; accidents, labor disputes and other risks of the mining industry; delays in obtaining governmental approvals; government regulation of mining operations; environmental risks; title disputes or claims; limitations on insurance coverage and the timing and possible outcome of litigation. Although the Company has attempted to identify important factors that could affect the Company and may cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, do not place undue reliance on forward-looking statements. All statements are made as of the date of this news release and the Company is under no obligation to update or alter any forward-looking statements except as required under applicable securities laws.

Forward-looking statements are based on assumptions that the Company believes to be reasonable, the merits of the mineral properties of the Company, the accuracy of the mineral resource estimates of the Company, mineral exploration and development costs; expected trends in mineral prices and currency exchange rates; that the Company's activities will be in accordance with the Company's public statements and stated goals; that there will be no material adverse change affecting the Company or its properties; that all required approvals will be obtained and that there will be no significant disruptions affecting the Company or its properties.

Contacts:
Pan American Goldfields Ltd.
Emilio Alvarez
CEO
+1-416-848-9407
www.panamerican-goldfields.com/index.html

"The Company was unable to obtain certain financial information necessary to complete the preparation of the Company's Form 10-Q for the period ended November 30, 2013 from Minera Rio Tinto, S.A. de C.V., the Company's development partner for its Cieneguita Project, in time for meeting the original filing deadline. As a result of this delay, the Company is unable to file its quarterly report on Form 10-Q by the prescribed due date without unreasonable effort or expense. The Company expects to file within the extension period."

http://archive.fast-edgar.com//20140114/AM22T22CZ225F2Z222252CN627S5BZ222262/

Golden Arrow to Commence Share Buy Back

2013-11-19 13:49 ET - News Release

Mr. Joseph Grosso reports

GOLDEN ARROW ANNOUNCES INTENTION TO MAKE A NORMAL COURSE ISSUER BID

The TSX Venture Exchange has accepted a notice of intention to make a normal course issuer bid which was filed by Golden Arrow Resources Corp. with the exchange.

Pursuant to the terms of the bid, Golden Arrow will purchase its own common shares for cancellation through the facilities of the exchange at the prevailing market price. The number of common shares purchased by Golden Arrow will in no event be in excess of 5 per cent of the issued and outstanding common shares at the date the bid commences, such amount not to exceed one million common shares of the 41,823,655 currently issued and outstanding common shares. Golden Arrow will effect purchases at varying times commencing on or after Nov. 25, 2013, and continuing until no later than Nov. 25, 2014, or on such earlier date as Golden Arrow may complete its purchases pursuant to the bid or as it may otherwise determine.

Golden Arrow is engaging in the bid because it believes that the market price of its common shares does not properly reflect the underlying value of Golden Arrow. The objective of the bid is to provide market stability for the benefit of the company's shareholders. Market purchases pursuant to the bid will be conducted through Steve Burns of Global Maxfin Capital Inc.

Shareholders may obtain a copy of the notice of intention to make a normal course issuer bid (Form 5G), without charge, by contacting Golden Arrow.




http://www.goldenarrowresources.com/s/NewsReleases.asp?ReportID=611947&_Type=News-Releases&_Title=Golden-Arrow-Announces-Intention-to-Make-a-Normal-Course-Issuer-Bid

Pan American Goldfields Clarifies Its Disclosure
Pan American Goldfields Clarifies Its Disclosure

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 4, 2013) - As a result of a review by the British Columbia Securities Commission ("the BCSC"), the securities regulatory authority in the Province of British Columbia, Pan American Goldfields Ltd. (the "Company") (OTCQX:MXOM) is issuing the following news release to clarify the Company's disclosure, based on discussions between the management team and the BCSC.

Technical Report Compliance:

The review by the BCSC has identified a number of technical compliance and filing issues with respect to the technical report entitled "Cieneguita Project, Preliminary Economic Assessment, Chihuahua, Mexico", by M3 Engineering and Technology Corporation, dated May 16, 2013 (the "Technical Report"). The updated mineral resource estimate and preliminary economic assessment are not supported by a compliant, fully independent NI 43-101 technical report, contrary to NI 43-101, and should not be relied on until they are independently verified and supported by an amended technical report. To correct the current situation going forward, the Company is working with the relevant Qualified Persons and is correcting the issues and intends to file an amended Technical Report on or before 25th November, 2013.

Clarification of previous disclosure:

The review by the BCSC has identified a number of disclosure issues with respect to the Technical Report, also occurring in the Company's news releases, website, and investor materials. Specifically:

1. Non-compliant disclosure of Preliminary Economic Assessment (PEA)

In its previous news releases, on its website, and investor presentation, the Company referred to the results of a PEA in a manner contrary to NI 43-101. Disclosure did not include prominent cautionary language required by section 2.3(3) and 3.4(e) of NI 43-101. The Company clarifies that the preliminary economic assessment is preliminary in nature, that it includes inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves, and there is no certainty that the preliminary economic assessment will be realised. Mineral resources that are not mineral reserves do not have demonstrated economic viability.

Disclosure of PEA results also included potentially misleading promotional information, which disclosed or implied the PEA demonstrates economic viability. This is contrary to the preliminary nature of a PEA and the required cautionary language and such disclosure is hereby retracted and investors are cautioned that such disclosure should not be relied upon. Going forward, the Company will ensure that the required proximate cautionary language will appear with all disclosure of results of the PEA.

2. Reporting Gross In-Situ Metal Value

The company's June 12, 2013 news release highlighted a gross metal value for the material used in the PEA. However, the use of gross in-situ value is misleading because it fails to take into consideration operating and capital costs, recoveries, smelter costs and other factors relating to the potential mining, extraction and recovery of metals and such disclosure is hereby retracted and investors are cautioned that such disclosure should not be relied upon.

3. Non-compliant disclosure of Mineral Resources

The Company occasionally reported mineral resources for its Cieneguita mineral property that were contrary to section 2.2 and 3.4 of NI 43-101 because the estimates omitted classification, tonnage, and grade and only disclosed gross contained metal quantities. In addition, estimates did not disclose resource classes separately.

"We are committed to achieving the highest standards of excellence in meeting the requirements of the regulatory authorities" commented CEO, Emilio Alvarez. "As part of this process, our technical disclosure must also comply with the requirements of Canadian National Instrument 43-101 "Standards of Disclosure for Mineral Projects" in all respects, and we are committed to meeting that objective and enhancing the value of the Company for all our shareholders."

About Pan American Goldfields Ltd.

Pan American Goldfields is a precious metals mining and exploration company. Its focus is the production of gold and silver and the development and expansion of its Cieneguita mine in Mexico's booming Sierra Madre gold-silver belt.

On behalf of the Board of Directors,

Emilio Alvarez, Director

Safe Harbor Disclosure

The information in this press release contains forward-looking statements regarding future events or the future financial performance of the Company. Please note that any statements that may be considered forward-looking are based on projections; that any projections involve judgment, and that individual judgments may vary. Moreover, these projections are based only on limited information available to us now, which is subject to change. Although those projections and the factors influencing them will likely change, we are under no obligation to inform you if they do. Actual results may differ substantially from any such forward looking statements as a result of various factors, many of which are beyond our control, including, among others, the timing and outcome of our feasibility study on our Cieneguita Project; the costs and results of our initial production activities on our Cieneguita Project; the future financial and operating performances of our projects; the estimation of mineral resources and the realization of mineral reserves, if any, on our existing and any future projects; the timing of exploration, development, and production activities and estimated future production, if any; estimates related to costs of production, capital, operating and exploration expenditures; requirements for additional capital and our ability to raise additional capital on a timely basis and on acceptable terms; government regulation of mining operations, environmental risks, reclamation and rehabilitation expenses; title disputes or claims against our existing and any future projects; and the future price of gold, silver, or other minerals. These and other factors can be found in our filings with the SEC. The Company undertakes no obligation to release publicly the results of any revision to these forward-looking statements to reflect events or circumstances following the date of this release.

Pan American Goldfields Ltd.

604-340-8678

info@panamgoldfields.com

www.panamgoldfields.com

Read more at http://www.stockhouse.com/companies/bullboard/mxom/pan-american-goldfields-ltd?postid=21876275#4mJT0O7bHltr1KoQ.99

Record Volume

GARWF traded more volume today than any other day since its listing... What is up???

Golden Arrow Resources - Chinchillas Silver Project, Argentina

Craig is gone soon???

Good... Maybe it will start to trade again with a more experienced person looking after the shareholders...

Why bother?? The release says nothing and who puts out news on a Friday afternoon?? Amateurs...